Currently, we do not believe enough evidence exists around side effects of GLP-1 RAs, but one thing is certain
GLP-1 medications may also affect other aspects of eye health, according to a 2025 study in JAMA Network
Several human studies have shown that the GLP-1 secretory response is impaired in obese subjects with postprandial hyperglycemia, although conflicting results have also been reported [20,21,22]
Common side effects associated with Mounjaro include: gastrointestinal disturbances such as nausea, diarrhea, and vomiting, as well as potential risks of thyroid C-cell tumors
But the situation with Ousia shows the pitfalls of navigating the world of online compounded obesity drugs, which includes legitimate businesses as well as some unlicensed or unregistered ones
Growing consumer awareness of obesity health risks and treatment options is driving increased consultation rates with endocrinology specialists